Adams Eddie W, Ratner Daniel M, Bokesch Heidi R, McMahon James B, O'Keefe Barry R, Seeberger Peter H
Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Chem Biol. 2004 Jun;11(6):875-81. doi: 10.1016/j.chembiol.2004.04.010.
Defining HIV envelope glycoprotein interactions with host factors or binding partners advances our understanding of the infectious process and provides a basis for the design of vaccines and agents that interfere with HIV entry. Here we employ carbohydrate and glycoprotein microarrays to analyze glycan-dependent gp120-protein interactions. In concert with new linking chemistries and synthetic methods, the carbohydrate arrays combine the advantages of microarray technology with the flexibility and precision afforded by organic synthesis. With these microarrays, we individually and competitively determined the binding profiles of five gp120 binding proteins, established the carbohydrate structural requirements for these interactions, and identified a potential strategy for HIV vaccine development.
明确HIV包膜糖蛋白与宿主因子或结合伴侣之间的相互作用,有助于我们深入了解感染过程,并为设计干扰HIV进入的疫苗和药物提供依据。在此,我们利用碳水化合物和糖蛋白微阵列来分析聚糖依赖性的gp120-蛋白质相互作用。结合新的连接化学方法和合成方法,碳水化合物阵列将微阵列技术的优势与有机合成所提供的灵活性和精确性结合起来。利用这些微阵列,我们分别和竞争性地确定了五种gp120结合蛋白的结合谱,确定了这些相互作用的碳水化合物结构要求,并确定了一种潜在的HIV疫苗开发策略。